Preclinical development strategy formulation
      Expertise with both FDA, CFDA regulations and guidelines for product characteristics, indications, development strategies to develop non-clinical development plan.
     Flexible according to the registration environment, the MoA or product type, pre-clinical data development strategy

Preclinical pharmacological toxicology trials
      Comprehensive assessment of technical expertise and quality assurance system selection to ensure qualified labs are utilized
     Work with internal and external experts to develop a comprehensive scientific test program, taking the molecule’s properties into account
     Pharmacokinetics and immunogenicity of biological macromolecules 
     Manage the implementation of non-clinical research to ensure project progress and quality
     Continuously provide scientific guidance throughout the preclinical study period, and adjust the trial protocol in a timely manner in response to new and emerging data

Our technical advantages and characteristics of services:
     Study on Immunogenicity of Biomacromolecule Drugs and Pharmacokinetic Methods
Follow us
Contact Us
   +86 21 5018 6802
    Ste.2-301,1199 Landian Road,Pudong District,Shanghai 201318,China

         Copyright © 2014 - 2017 上海博威生物医药有限公司 版权所有